Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood Clots.
clot retraction
computational modeling
fibrin
hemostasis
platelet
thrombosis
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
06 03 2021
06 03 2021
Historique:
received:
18
02
2021
accepted:
01
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Primary hemostasis consists in the activation of platelets, which spread on the exposed extracellular matrix at the injured vessel surface. Secondary hemostasis, the coagulation cascade, generates a fibrin clot in which activated platelets and other blood cells get trapped. Active platelet-dependent clot retraction reduces the clot volume by extruding the serum. Thus, the clot architecture changes with time of contraction, which may have an important impact on the healing process and the dissolution of the clot, but the precise physiological role of clot retraction is still not completely understood. Since platelets are the only actors to develop force for the retraction of the clot, their distribution within the clot should influence the final clot architecture. We analyzed platelet distributions in intracoronary thrombi and observed that platelets and fibrin co-accumulate in the periphery of retracting clots in vivo. A computational mechanical model suggests that asymmetric forces are responsible for a different contractile behavior of platelets in the periphery versus the clot center, which in turn leads to an uneven distribution of platelets and fibrin fibers within the clot. We developed an in vitro clot retraction assay that reproduces the in vivo observations and follows the prediction of the computational model. Our findings suggest a new active role of platelet contraction in forming a tight fibrin- and platelet-rich boundary layer on the free surface of fibrin clots.
Identifiants
pubmed: 33800866
pii: cells10030584
doi: 10.3390/cells10030584
pmc: PMC7998474
pii:
doi:
Substances chimiques
Fibrin
9001-31-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fondation pour la Recherche Médicale
ID : DEI20151234416
Organisme : Université Grenoble Alpes
ID : AGIR-POLE FRAG15CS08
Organisme : CSRD VA
ID : 1
Pays : United States
Références
J Intern Med. 2014 Dec;276(6):618-32
pubmed: 25156650
Sci Rep. 2020 Mar 20;10(1):5112
pubmed: 32198356
Blood. 2014 Sep 11;124(11):1824-31
pubmed: 24951426
J Clin Invest. 2018 Aug 1;128(8):3356-3368
pubmed: 29723163
Clin Hemorheol Microcirc. 2008;39(1-4):243-6
pubmed: 18503132
Nat Commun. 2017 Nov 2;8(1):1274
pubmed: 29097692
Neurol Med Chir (Tokyo). 2014;54(11):895-900
pubmed: 25367586
Blood. 2014 Mar 6;123(10):1596-603
pubmed: 24335500
Blood. 2017 Dec 7;130(23):2453-2462
pubmed: 29074499
Sci Rep. 2020 Jul 17;10(1):11910
pubmed: 32680988
J Thromb Haemost. 2019 Feb;17(2):361-370
pubmed: 30582674
Blood. 2012 Nov 15;120(20):4215-8
pubmed: 22955928
Circ J. 2018 Feb 23;82(3):866-873
pubmed: 29176266
Trends Cell Biol. 2018 Jul;28(7):541-550
pubmed: 29605547
Neurology. 2019 Oct 29;93(18):e1686-e1698
pubmed: 31541014
Platelets. 2000 Feb;11(1):49-55
pubmed: 10938882
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):37-47
pubmed: 30580561
Science. 2008 Apr 25;320(5875):456-7
pubmed: 18436761
Thromb Haemost. 2015 Jun;113(6):1258-69
pubmed: 25739375
Cardiovasc Res. 2019 May 1;115(6):1026-1028
pubmed: 30689756
Blood. 2014 Aug 7;124(6):e4-e10
pubmed: 24990887
Nat Mater. 2011 Jan;10(1):61-6
pubmed: 21131961
Blood. 2008 Jul 1;112(1):90-9
pubmed: 18310501
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2938-45
pubmed: 23087356
Blood. 2007 Nov 1;110(9):3183-91
pubmed: 17664350
Circ J. 2004 Apr;68(4):308-14
pubmed: 15056826
Stroke. 2020 Dec;51(12):3640-3650
pubmed: 33040705